Prostate cancer treatment with exercise medicine

Abstract

Exercise can reduce the risk of death in men with prostate cancer. Although the effect was demonstrated over 10 years ago, exercise medicine is still not recognised as a critical therapy in cancer management. Nevertheless, the evidence base is building, and an ongoing randomised controlled trial has been designed to assess whether a targeted and highly sophisticated exercise medicine intervention causes a survival advantage in men with metastatic castrate‐resistant prostate cancer.